Sandostatin LAR
FDA Approves Lymphoseek to Locate Lymph Nodes »
"The U.S. Food and Drug Administration today approved Lymphoseek (technetium Tc 99m tilmanocept) Injection, a radioactive diagnostic imaging agent that helps doctors locate lymph nodes in patients with breast cancer or melanoma who are undergoing "...
Read the FDA Approves Lymphoseek to Locate Lymph Nodes article »
Sandostatin LAR
PATIENT INFORMATION
Patients with carcinoid tumors and VIPomas should be advised to adhere closely to their scheduled return visits for reinjection in order to minimize exacerbation of symptoms.
Patients with acromegaly should also be urged to adhere to their return visit schedule to help assure steady control of GH and IGF-1 levels.
Last reviewed on RxList: 10/10/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Sandostatin LAR Information
Sandostatin LAR - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Cancer
Get the latest treatment options.






